ArticlePharmacoEconomics - open2017
Evaluating the Treatment Costs for Uncomplicated Malaria at a Public Healthcare Facility in Nigeria and the Implications.
Article in PharmacoEconomics - open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.
- The economic burden of malaria in Africa: a systematic review of cost of illness studies.Malaria journal · 2025Pooled it
- Costs and Cost-Effectiveness of Malaria Control Interventions: A Systematic Literature Review.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2021Pooled it
- Insecticide-treated net utilization and associated factors among infants in Southwestern Nigeria.Malaria journal · 2026Article
- Economic evaluation of anti-malarial drug policies across presidential regimes in Nigeria: A comparative analysis from 1999 to present.PloS one · 2026Article
- Article
- Health system challenges and facilitators associated with adaptive cycling deployment of multiple first-line treatment for uncomplicated malaria: a pilot study in a malaria-endemic region of Kenya.Malaria journal · 2025Article
- Multiple first-line therapeutic strategies to mitigate artemisinin resistance: cost analysis of a pilot study from a health system perspective in Kaya health district, Burkina Faso.Malaria journal · 2025Article
- Menstrual Cycle Matters in Host Attractiveness to Mosquitoes and Topical Repellent Protection.Insects · 2025Article
- Who benefits from the donor-supported malaria programme in Enugu State, Nigeria? A benefit incidence analysis.PLOS global public health · 2025Article
- Diversity and Species Composition of Midgut Symbiotic Bacteria inJournal of tropical medicine · 2024Article
- Economic Burden of Mosquito-Borne Diseases in Low- and Middle-Income Countries: Protocol for a Systematic Review.JMIR research protocols · 2023Article
- The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso.Malaria journal · 2023Review
- Economic Burdens of Uncomplicated Malaria in Primary Health Care (PHC) Facilities of Plateau State, Nigeria: Patients' Perspectives.International journal of environmental research and public health · 2023Article
- Economic evaluation of a leprosy innovation project in Northern Nigeria: cost-effectiveness analysis.Cost effectiveness and resource allocation : C/E · 2022Article
- A cost analysis of the diagnosis and treatment of malaria at public health facilities and communities in three districts in Rwanda.Malaria journal · 2022Article
- Addressing child health inequity through case management of under-five malaria in Nigeria: an extended cost-effectiveness analysis.Malaria journal · 2022Article
- Financing malaria.PLOS global public health · 2022Review
- Article
- Article
- The economic burden of malaria on households and the health system in a high transmission district of Mozambique.Malaria journal · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAccurate information on the facility costs of treatment is essential to enhance decision making and funding for malaria control.
objectiveThe objective of this study was to estimate the costs of providing treatment for uncomplicated malaria through a public health facility in Nigeria.
methodsHospital costs were estimated from a provider perspective, applying a standard costing procedure. Capital and recurrent expenditures were estimated using an ingredient approach combined with step-down methodology. Costs attributable to malaria treatment were calculated based on the proportion of malaria cases to total outpatient visits. The costs were calculated in local currency [Naira (N)] and converted to US dollars at the 2013 exchange rate.
resultsTotal annual costs of N28.723 million (US$182,953.65) were spent by the facility on the treatment of uncomplicated malaria, at a rate of US$31.49 per case, representing approximately 25% of the hospital's total expenditure in the study year. Personnel accounted for over 82.5% of total expenditure, followed by antimalarial medicines at 6.6%. More than 45% of outpatients visits were for uncomplicated malaria. Changes in personnel costs, drug prices and malaria prevalence significantly impacted on the study results, indicating the need for improved efficiency in the use of hospital resources.
conclusionMalaria treatment currently consumes a considerable amount of resources in the facility, driven mainly by personnel cost and a high proportion of malaria cases. There is scope for enhanced efficiency to prevent waste and reduce costs to the provider and ultimately the consumer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.